Advisory 253 Brand vs Generic (DAW6) Changes to Maryland Medicaid’s Preferred Drug List (PDL)

The Office of Pharmacy Services (OPS) wants to alert you that effective December 9, 2023:

• Brand and generic Trileptal (Oxcarbazepine) suspension will both be preferred. Claims for brand Trileptal must be submitted with DAW 6 code and will be priced appropriately. A Maryland Department of Health (MDH) MedWatch form will not be required. Claims with any other DAW code will reject.

If any problems are encountered during the online claim adjudication, contact Conduent 24-hour Help Desk at 800-932-3918 for additional system overrides related to the use of the correct DAW code (for example, if there is other primary insurance).

Please refer to our website for the Preferred Drug List (PDL) and Brand Preferred over Generics List:

https://health.maryland.gov/mm...

All Advisories are available online on MDH’s web link at: https://health.maryland.gov/mm... Advisories.aspx